<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35166879</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>03</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>03</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1432-2323</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>46</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>World journal of surgery</Title>
          <ISOAbbreviation>World J Surg</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Low-Cost Vacuum Assisted Core Needle Biopsy Technique for Breast Lumps.</ArticleTitle>
        <Pagination>
          <StartPage>1445</StartPage>
          <EndPage>1450</EndPage>
          <MedlinePgn>1445-1450</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00268-022-06475-3</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Core biopsy has replaced fine needle aspiration cytology in the assessment of breast lumps to diagnose malignancy and is now standard of care in developed countries. Unfortunately, cost of core biopsy system is a major limitation in low-and middle-income countries (LMICs). This prompted us to devise and appraise a low-cost technique of core biopsy using negative pressure.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We devised and prospectively evaluated a simple model of core biopsy (vacuum assisted core needle biopsy-VACNB) using a 50 ml syringe, a 10 ml syringe and a 14G needle.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">57 consecutive women (median age 42.66 years) with breast lumps (median diameter 5.2 cm) underwent VACNB. The sensitivity for diagnosing malignancy was 92%, specificity was 100%, and diagnostic accuracy was 92.98%. The positive predictive value of this technique was 100%, and negative predictive value was 63.64%. The cost (~ 5.5 USD) of the system was significantly less than the cost of core biopsy needle (~ 41.00 USD) and vacuum assisted breast biopsy needle (~ 341.00 USD) in India.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Frugal innovations are needed to overcome cost constraints in LMICs. Our low-cost VACNB technique is easy to use and accurate.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s) under exclusive licence to Société Internationale de Chirurgie.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yadav</LastName>
            <ForeName>Sanjay Kumar</ForeName>
            <Initials>SK</Initials>
            <Identifier Source="ORCID">0000-0002-0682-4970</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, NSCB Medical College, Jabalpur, India. sky1508@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Carpenter</LastName>
            <ForeName>Ashutosh</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, NSCB Medical College, Jabalpur, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rai</LastName>
            <ForeName>Roshni</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, NSCB Medical College, Jabalpur, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jha</LastName>
            <ForeName>Chandan Kumar</ForeName>
            <Initials>CK</Initials>
            <AffiliationInfo>
              <Affiliation>Endocrine Surgery, AIIMS, Patna, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sharma</LastName>
            <ForeName>Dhananjaya</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, NSCB Medical College, Jabalpur, India.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>02</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>World J Surg</MedlineTA>
        <NlmUniqueID>7704052</NlmUniqueID>
        <ISSNLinking>0364-2313</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D044963" MajorTopicYN="N">Biopsy, Fine-Needle</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062005" MajorTopicYN="N">Biopsy, Large-Core Needle</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001940" MajorTopicYN="Y">Breast</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001943" MajorTopicYN="Y">Breast Neoplasms</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D061705" MajorTopicYN="N">Image-Guided Biopsy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014618" MajorTopicYN="N">Vacuum</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>15</Day>
          <Hour>12</Hour>
          <Minute>18</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35166879</ArticleId>
        <ArticleId IdType="doi">10.1007/s00268-022-06475-3</ArticleId>
        <ArticleId IdType="pii">10.1007/s00268-022-06475-3</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>India State-Level Disease Burden Initiative Cancer Collaborators (2018) The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990–2016 [published correction appears in Lancet Oncol. 2018 Oct 3]. Lancet Oncol 19(10):1289–1306. https://doi.org/10.1016/S1470-2045(18)30447-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1470-2045(18)30447-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clarke D, Sudhakaran N, Gateley CA (2011) Replace fine needle aspiration cytology in the triple assessment of breast cancer. Ann R Coll Surg Engl 83(2):2503348</Citation>
        </Reference>
        <Reference>
          <Citation>Bujang MA, Adnan TH (2016) Requirements for minimum sample size for sensitivity and specificity analysis. J Clin Diagn Res 10(10):YE01–YE06. https://doi.org/10.7860/JCDR/2016/18129.8744</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7860/JCDR/2016/18129.8744</ArticleId>
            <ArticleId IdType="pubmed">27891446</ArticleId>
            <ArticleId IdType="pmc">5121784</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cusick JD, Dotan J, Jaecks RD, Boyle WT Jr (1990) The role of tru-cut needle biopsy in the diagnosis of carcinoma of the breast. Surg Gynecol Obstet 170:407–410</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2183373</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barreto V, Hamed H, Griffiths AB, Hanby A, Chaudary MA, Fentiman IS (1991) Automatic needle biopsy in the diagnosis of early breast cancer. Eur J Surg Oncol 17:237–239</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2044776</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vargas HI, Masood S (2003) Implementation of a minimally invasive breast biopsy program in countries with limited resources. Breast J 9(S2):S81–S85. https://doi.org/10.1046/j.1524-4741.9.s2.8.x (PMID: 12713501)</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1524-4741.9.s2.8.x</ArticleId>
            <ArticleId IdType="pubmed">12713501</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Masood S, Vass L, Ibarra JA et al (2008) Breast pathology guidelines implementation in low‐and middle‐income countries. Cancer 113(8 suppl):2297–2304</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cncr.23833</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carlson RW, Scavone J, Koh W-J et al (2016) NCCN Framework for resource stratification: a framework for providing and improving global quality oncology care. J Natl Compr Cancer Netw 14:961–969</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.6004/jnccn.2016.0103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang M, He X, Chang Y, Sun G, Thabane L (2017) A sensitivity and specificity comparison of fine needle aspiration cytology and core needle biopsy in evaluation of suspicious breast lesions: a systematic review and meta-analysis. Breast 31:157–166. https://doi.org/10.1016/j.breast.2016.11.009</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.breast.2016.11.009</ArticleId>
            <ArticleId IdType="pubmed">27866091</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
